Search Results for "Ondansetron Im"

14:57 EDT 28th September 2016 | BioPortfolio

Matching Channels


Matching News

Ondansetron Should Not Be First Choice for Nausea in Pregnancy

Ondansetron was associated with a low risk for birth defects in neonates who were exposed during the first trimester of pregnancy, and the incidence of cardiac malformations may be increased slightly....

Bekinda Ondansetron: Phase II started

Ondansetron for Pregnancy-Associated Nausea and Vomiting

First-trimester use seems safe, although data are still limited.

Midatech launches chemo side effect drug in the US

Drug delivery specialist Midatech (LON:MPTH) will commercially launch Zuplenz, its anti-vomiting drug for chemo and radiotherapy patients, in the US this week. Midatech acquired the treatment from G...

Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz(R) (ondansetron) oral soluble film and Oravig(R) (miconazole) orally-dissolving buccal tablet

Midatech Pharma PLC  ("Midatech" or the "Company") Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz ® (ondansetron) oral soluble film and Oravig ® (miconaz...

Weighing The Risks And Benefits Of A Drug Prescribed To Pregnant Women For Extreme Morning Sickness

A new study suggests that the drug ondansetron, sold as Zofran, does not increase the risk of birth defects when taken for severe nausea and vomiting during pregnancy.

BRIEF-Lincoln Pharma develops new NDDS formulation in India

* Developed new NDDS formulation Ondansetron Oral Spray (Domi Up) first time in India Source text: Further company coverage:

Study finds no evidence linking anti-nausea drug to birth defects

Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart...

Matching PubMed Articles

Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms.

Ondansetron improves the success of oral rehydration in children with gastroenteritis. In postoperative adults, ondansetron has been shown to prolong the corrected QT (QTc). The aim of the study was t...

Risk of Ventricular Arrhythmias and Association with Ondansetron.

To evaluate the use of ondansetron in a tertiary care pediatric health system, assess the incidence of ventricular tachyarrhythmia within 24 hours of ondansetron, and identify the characteristics of c...

Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study.

Therapy for moderate to severe acute food protein induced enterocolitis syndrome (FPIES) typically consists of intravenous fluids and corticosteroids (traditional therapy). Ondansetron has been sugges...

Intravenous Ondansetron and the QT Interval in Adult Emergency Department Patients: An Observational Study.

Ondansetron is known to cause QT interval prolongation, but this effect and clinical significance has not been prospectively studied in adult emergency department (ED) patients. The primary objective ...

Meta-analysis of randomized controlled trials on the efficacy and safety of ondansetron in preventing postanesthesia shivering.

Considerable controversy exists regarding the efficacy of ondansetron in preventing postanesthesia shivering (PAS). We performed a meta-analysis of randomized controlled trials to examine the controve...

Search Whole site using Google

Quick Search
Advertisement Advertisement